Mecwins Selected by Almenara Capital Partners for Its New LifeTech Innovation Fund Portfolio
We are pleased to share that Mecwins has [...]
Destina Genomics Appoints New CEO as Mecwins Strengthens Partnership
Destina Genomics, a biotechnology company specializing in advanced [...]
Leader in Cardiology Joins as Scientific Advisor to Support Our Clinical Solutions
We’re thrilled to welcome Dr. Rio Aguilar Torres [...]
Mecwins Achieves DNSH Certification, Reinforcing Commitment to Sustainability
We are proud to announce that our company has [...]
Immunosensor Research to the Next Level
Following our recent publication on improving immunosensor performance through [...]
Mecwins Joins the Enterprise Europe Network with New Profile on Scientific Instrumentation
Mecwins is proud to announce the publication of [...]
Optimizing surface chemistry to boost biosensor performance
At Mecwins, innovation means digging deep into the details—right [...]
Mecwins Strengthens its European Partnering at the Cluster Health Horizon Europe Brokerage Event 2025
Madrid, May 8, 2025 Mecwins participated in the [...]
